PMS of Spesolimab I.V. in GPP Patients With Acute Symptoms

Clinical trial NCT05670821 · COMPLETED

Trial details

NCT number: NCT05670821
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Study type: OBSERVATIONAL

Generalized Pustular Psoriasis

Start date: 2023-04-18
Primary completion: 2025-10-06
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.